Fmr LLC boosted its stake in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 16.8% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,192,885 shares of the company’s stock after acquiring an additional 315,073 shares during the quarter. Fmr LLC’s holdings in DocuSign were worth $136,156,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Inspire Investing LLC bought a new stake in shares of DocuSign during the third quarter valued at approximately $911,000. Charles Schwab Investment Management Inc. boosted its position in DocuSign by 1.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company’s stock valued at $82,478,000 after buying an additional 16,014 shares during the last quarter. Comerica Bank increased its stake in shares of DocuSign by 228.8% in the 1st quarter. Comerica Bank now owns 28,901 shares of the company’s stock valued at $1,721,000 after buying an additional 20,110 shares during the period. International Assets Investment Management LLC raised its position in shares of DocuSign by 5,660.8% during the third quarter. International Assets Investment Management LLC now owns 438,914 shares of the company’s stock worth $27,252,000 after acquiring an additional 431,295 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. raised its position in shares of DocuSign by 7.1% during the third quarter. Robeco Institutional Asset Management B.V. now owns 1,296,517 shares of the company’s stock worth $80,501,000 after acquiring an additional 85,987 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.
DocuSign Trading Up 0.2 %
DOCU stock opened at $80.45 on Wednesday. DocuSign, Inc. has a 1-year low of $44.34 and a 1-year high of $86.75. The firm has a market cap of $16.33 billion, a PE ratio of 16.97, a P/E/G ratio of 8.31 and a beta of 0.92. The business’s 50-day moving average price is $72.86 and its two-hundred day moving average price is $61.36.
Insider Activity
In other DocuSign news, Director Teresa Briggs sold 534 shares of the business’s stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $56.56, for a total value of $30,203.04. Following the sale, the director now owns 7,202 shares in the company, valued at approximately $407,345.12. The trade was a 6.90 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Allan C. Thygesen sold 7,763 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $80.54, for a total transaction of $625,232.02. Following the transaction, the chief executive officer now directly owns 100,062 shares of the company’s stock, valued at $8,058,993.48. This represents a 7.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 69,596 shares of company stock worth $4,441,529 over the last quarter. 1.66% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
A number of analysts recently commented on DOCU shares. Royal Bank of Canada lifted their price objective on DocuSign from $52.00 to $57.00 and gave the stock a “sector perform” rating in a research report on Friday, September 6th. Robert W. Baird lifted their price target on shares of DocuSign from $55.00 to $59.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Citigroup raised their price objective on shares of DocuSign from $86.00 to $87.00 and gave the company a “buy” rating in a research note on Friday, September 6th. JPMorgan Chase & Co. lifted their target price on shares of DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a report on Tuesday. Finally, Jefferies Financial Group increased their price target on DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Tuesday. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, DocuSign has an average rating of “Hold” and an average price target of $70.73.
Get Our Latest Research Report on DocuSign
DocuSign Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Further Reading
- Five stocks we like better than DocuSign
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Why Invest in High-Yield Dividend Stocks?
- Netflix Is On Track To Hit $1,000 By Christmas
- ETF Screener: Uses and Step-by-Step Guide
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.